Tybourne Capital Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.45M | Sell |
|
|||||
|
2025
Q2 | $1.71M | Buy |
|
|||||
|
2025
Q1 | $1.53M | Hold |
|
|||||
|
2024
Q4 | $2.91M | Hold |
|
|||||
|
2024
Q3 | $3.54M | Hold |
|
|||||
|
2024
Q2 | $3.93M | Hold |
|
|||||
|
2024
Q1 | $15.2M | Hold |
|
|||||
|
2023
Q4 | $14.6M | Hold |
|
|||||
|
2023
Q3 | $19.3M | Hold |
|
|||||
|
2023
Q2 | $27.1M | Sell |
|
|||||
|
2023
Q1 | $28.1M | Sell |
|
|||||
|
2022
Q4 | $44.9M | Sell |
|
|||||
|
2022
Q3 | $49.9M | Sell |
|
|||||
|
2022
Q2 | $68.2M | Hold |
|
|||||
|
2022
Q1 | $112M | Sell |
|
|||||
|
2021
Q4 | $221M | Sell |
|
|||||
|
2021
Q3 | $178M | Hold |
|
|||||
|
2021
Q2 | $142M | Hold |
|
|||||
|
2021
Q1 | $116M | Hold |
|
|||||
|
2020
Q4 | $138M | Hold |
|
|||||
|
2020
Q3 | $87.1M | Hold |
|
|||||
|
2020
Q2 | $128M | Buy |
|